ADIM
CRTO icon

Alpha DNA Investment Management’s Criteo S.A. CRTO Stock Holding History

Alpha DNA Investment Management’s Portfolio CRTO Stock Details CRTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,541
Closed -$473K – 214
2024
Q2 		$473K Buy
+12,541
New +$459K 0.18% 121
2022
Q1 		– Sell
-40,440
Closed -$1.57M – 126
2021
Q4 		$1.57M Buy
40,440
+1,509
+4% +$58K 0.99% 48
2021
Q3 		$1.43M Buy
+38,931
New +$1.5M 0.97% 49
2021
Q2 		– Sell
-87
Closed -$3K – 214
2021
Q1 		$3K Buy
+87
New +$2.39K ﹤0.01% 461

Other funds holding CRTO

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Alpha DNA Investment Management's CRTO Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Criteo S.A. (CRTO) in Q3 2024, closing a stake of 12,541 shares — an estimated $473K sold.

Alpha DNA Investment Management first reported a position in CRTO in Q1 2021 and held it in 4 quarters. The position peaked at $1.57M in Q4 2021. 176 funds tracked by Wall St. Rank hold CRTO as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Criteo S.A. position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 12,541 Criteo S.A. shares in Q3 2024, an estimated $473K.
  • Alpha DNA Investment Management first reported a position in Criteo S.A. in Q1 2021 and held it in 4 quarters.
  • Alpha DNA Investment Management's Criteo S.A. position peaked at $1.57M in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Criteo S.A. as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.